Monyk Dias Carneiro
Research Subjects
Monyk Dias Carneiro has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Ivia Carmem Talieri
2 shared publicationsNayane Magda Santos de Oliveira
2 shared publicationsVanessa Martins Fayad Milken
2 shared publications- Aline Maria Matos1 shared publication
Fernanda Nastri Gouvêa
1 shared publication- Fernanda Nastri Gouvêa
Universidade Federal de Uberlândia
1 shared publication
Latest Publications
- Open Access
- 25 September 2026
- Published by Elsevier in Topics in Companion Animal Medicine
- Vol. 73
Reassessing neonatal hypoglycemia in kittens: Clinical relevance beyond the laboratory value
- 25 September 2026
- Published by Elsevier in Topics in Companion Animal Medicine
- Vol. 73
Open AccessReassessing neonatal hypoglycemia in kittens: Clinical relevance beyond the laboratory value
- Open Access
- 12 May 2026
- Published by Universidade Federal do Rio Grande do Sul in Acta Scientiae Veterinariae
- Vol. 54
Reversal of Acute Kidney Injury Refractory to Conventional Treatment in a Cat: The Impact of Peritoneal Dialysis
Background: Acute kidney injury (AKI) in cats is associated with various causes, including poisoning, infectious diseases, ischemia, and tumors. Clinically, it presents with anorexia, vomiting, diarrhea, prostration, and dehydration. Laboratory findings often include azotemia, metabolic acidosis, and hyperkalemia. Standard treatment focuses on fluid therapy and correction of electrolyte disturbances. Peritoneal dialysis (PD) is indicated in cases of anuria, severe azotemia, or poisoning with dialyzable toxins. Although AKI is widely recognized in cats, there are few reports of PD used as a therapeutic tool in these cases. The present report aims to address this gap. Case: This report describes the case of a cat presented with anorexia, emesis, and diarrhea, possibly associated with the ingestion of a plant, although this was not clearly explained in the anamnesis. On physical examination, the patient was dehydrated (12%), jaundiced, and hypotensive (90 mmHg). Laboratory tests showed azotemia (creatinine 11.7 mg/dL), metabolic acidosis (pH 7.159; bicarbonate 11.1 mmol/L), hyperkalemia (potassium 7.40 mmol/L), direct hyperbilirubinemia (25 mg/dL), and increased liver enzyme activity. Ultrasound showed bilateral kidney, liver, and spleen enlargement. All the findings reported were in line with a diagnosis of intoxication, AKI, and cholangiohepatitis. Therapy with antiemetics, antioxidants, and correction of dehydration and systolic blood pressure was started, followed by dialysis. Twelve PD cycles were carried out using Peritosteril® with 1.5% glucose. After the initial sessions, the patient became alert and normorexic. By the end of therapy, azotemia (creatinine 2.07 mg/dL), metabolic acidosis (pH 7.286; bicarbonate 13.8 mmol/L) were corrected and serum potassium concentration (4.06 mmol/L) was normalized. The patient remained clinically healthy with normal laboratory values one year later. Discussion: Owing to the multiple etiologies of AKI, the identification of the exact cause remains undetermined in approximately one-third of patients, as in this case. More than 50% of cases involve nephrotoxic substances, and because the anamnesis reported possible interaction with the aloe vera plant, there probably is a correlation between this and kidney damage. There is a lack of studies proving the nephrotoxicity of aloe vera in cats. In humans and rodents, the association between substances in this plant and impaired kidney function has already been reported. PD was an effective treatment, with the patient surviving for >365 days, similar to other reports. The positive response included rapid correction of acidosis and hyperkalemia and a reduction in creatinine levels within 15 days. Therapeutic success is related to the reversible nature of the disease and the early onset of polyuria. Despite the good results, peritonitis is a common complication of PD, particularly with prolonged treatment. In the case reported herein, the patient developed peritonitis after 15 days with the abdominal drain, and the isolated bacteria were different from those usually described. This reinforces the importance of culture and antibiogram in the management of infections. It is concluded that PD was an effective and affordable alternative for the management of AKI in this cat. Although it involves an invasive technique, it requires fewer resources than hemodialysis and can be routinely performed by a trained team. The literature is still scarce on the subject, which highlights the importance of reports like this one to build clinical knowledge. Keywords: cats; azotemia; dialysis; nephrotoxicity
- 12 May 2026
- Published by Universidade Federal do Rio Grande do Sul in Acta Scientiae Veterinariae
- Vol. 54
Open AccessReversal of Acute Kidney Injury Refractory to Conventional Treatment in a Cat: The Impact of Peritoneal Dialysis
Background: Acute kidney injury (AKI) in cats is associated with various causes, including poisoning, infectious diseases, ischemia, and tumors. Clinically, it presents with anorexia, vomiting, diarrhea, prostration, and dehydration. Laboratory findings often include azotemia, metabolic acidosis, and hyperkalemia. Standard treatment focuses on fluid therapy and correction of electrolyte disturbances. Peritoneal dialysis (PD) is indicated in cases of anuria, severe azotemia, or poisoning with dialyzable toxins. Although AKI is widely recognized in cats, there are few reports of PD used as a therapeutic tool in these cases. The present report aims to address this gap. Case: This report describes the case of a cat presented with anorexia, emesis, and diarrhea, possibly associated with the ingestion of a plant, although this was not clearly explained in the anamnesis. On physical examination, the patient was dehydrated (12%), jaundiced, and hypotensive (90 mmHg). Laboratory tests showed azotemia (creatinine 11.7 mg/dL), metabolic acidosis (pH 7.159; bicarbonate 11.1 mmol/L), hyperkalemia (potassium 7.40 mmol/L), direct hyperbilirubinemia (25 mg/dL), and increased liver enzyme activity. Ultrasound showed bilateral kidney, liver, and spleen enlargement. All the findings reported were in line with a diagnosis of intoxication, AKI, and cholangiohepatitis. Therapy with antiemetics, antioxidants, and correction of dehydration and systolic blood pressure was started, followed by dialysis. Twelve PD cycles were carried out using Peritosteril® with 1.5% glucose. After the initial sessions, the patient became alert and normorexic. By the end of therapy, azotemia (creatinine 2.07 mg/dL), metabolic acidosis (pH 7.286; bicarbonate 13.8 mmol/L) were corrected and serum potassium concentration (4.06 mmol/L) was normalized. The patient remained clinically healthy with normal laboratory values one year later. Discussion: Owing to the multiple etiologies of AKI, the identification of the exact cause remains undetermined in approximately one-third of patients, as in this case. More than 50% of cases involve nephrotoxic substances, and because the anamnesis reported possible interaction with the aloe vera plant, there probably is a correlation between this and kidney damage. There is a lack of studies proving the nephrotoxicity of aloe vera in cats. In humans and rodents, the association between substances in this plant and impaired kidney function has already been reported. PD was an effective treatment, with the patient surviving for >365 days, similar to other reports. The positive response included rapid correction of acidosis and hyperkalemia and a reduction in creatinine levels within 15 days. Therapeutic success is related to the reversible nature of the disease and the early onset of polyuria. Despite the good results, peritonitis is a common complication of PD, particularly with prolonged treatment. In the case reported herein, the patient developed peritonitis after 15 days with the abdominal drain, and the isolated bacteria were different from those usually described. This reinforces the importance of culture and antibiogram in the management of infections. It is concluded that PD was an effective and affordable alternative for the management of AKI in this cat. Although it involves an invasive technique, it requires fewer resources than hemodialysis and can be routinely performed by a trained team. The literature is still scarce on the subject, which highlights the importance of reports like this one to build clinical knowledge. Keywords: cats; azotemia; dialysis; nephrotoxicity
- Open Access
- 29 March 2026
- Published by Elsevier in SSRN Electronic Journal
Reassessing neonatal hypoglycemia in kittens: clinical relevance beyond the laboratory value
The underdeveloped metabolism in newborn kittens, along with the quick use of liver sugar reserves and the limited ability to produce glucose, makes them prone to low blood sugar levels during this time. This condition may be potentially fatal, although reduced blood glucose values do not necessarily manifest with clinical signs. Fifteen neonatal kittens born to three clinically healthy pregnant queens were evaluated during the first three days of life. Apgar scoring was done daily, and blood glucose measurements began within the first hour after birth (T1), followed by evaluations every 2 hours, with a total of six measurements each day from T2 to T18. Samples were obtained via capillary puncture with alternating digital pads and analyzed using a glucometer validated for cats (Accu-Check® Active, Roche Diagnóstica Brasil Ltda). A total of 270 glycemic measurements were performed, demonstrating instability during the first hours of life. On the first day, there was a mean glucose concentration of 61.7 22.2 mg/dL. On the second day, it dropped to 53.9 16.5 mg/dL. On the third day, metabolic recovery occurred (68.5 14.7 mg/dL). All neonates maintained adequate Apgar scores and showed no clinical signs. Marked fluctuations in blood glucose levels were observed during the first 48 hours, with progressive stabilization by the third day, reflecting the maturation of neonatal metabolic homeostasis. Despite the laboratory diagnosis of hypoglycemia, none of the kittens exhibited clinical manifestations or required intervention.
- 29 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessReassessing neonatal hypoglycemia in kittens: clinical relevance beyond the laboratory value
The underdeveloped metabolism in newborn kittens, along with the quick use of liver sugar reserves and the limited ability to produce glucose, makes them prone to low blood sugar levels during this time. This condition may be potentially fatal, although reduced blood glucose values do not necessarily manifest with clinical signs. Fifteen neonatal kittens born to three clinically healthy pregnant queens were evaluated during the first three days of life. Apgar scoring was done daily, and blood glucose measurements began within the first hour after birth (T1), followed by evaluations every 2 hours, with a total of six measurements each day from T2 to T18. Samples were obtained via capillary puncture with alternating digital pads and analyzed using a glucometer validated for cats (Accu-Check® Active, Roche Diagnóstica Brasil Ltda). A total of 270 glycemic measurements were performed, demonstrating instability during the first hours of life. On the first day, there was a mean glucose concentration of 61.7 22.2 mg/dL. On the second day, it dropped to 53.9 16.5 mg/dL. On the third day, metabolic recovery occurred (68.5 14.7 mg/dL). All neonates maintained adequate Apgar scores and showed no clinical signs. Marked fluctuations in blood glucose levels were observed during the first 48 hours, with progressive stabilization by the third day, reflecting the maturation of neonatal metabolic homeostasis. Despite the laboratory diagnosis of hypoglycemia, none of the kittens exhibited clinical manifestations or required intervention.